Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
Reza Seyed Sharifi(St George's, University of London), Ivan Ahel(University of Oxford), Ria Weston(Manchester Metropolitan University), Ronald T. Hay(University of Dundee), Marianna Nicoletta Rossi(Roma Tre University), C. Denise Appel(National Institutes of Health), Gyula Timinszky(HUN-REN Szegedi Biológiai Kutatóközpont), Dragana Ahel(University of Manchester), Alexander Wan(St George's, University of London), Hamid Galehdari(Shahid Chamran University of Ahvaz), Michael A. Simpson(King's College London), Gytis Jankevicius(University of Basel), Ivan Matić(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Andrew H. Crosby(University of Exeter), Michael Tallis(University of Manchester), Rosa Morra(University of Manchester), R. Scott Williams(University of North Carolina at Chapel Hill), Andreas G. Ladurner(Max Planck Institute of Neurobiology), Jason G. Williams(National Institute of Environmental Health Sciences), Barry A. Chioza(University of Exeter), Barbara Golia(Ludwig-Maximilians-Universität München), J.M. Krahn(National Institutes of Health), Ege Ozkan(St George's, University of London), Richard C. Trembath(King's College London), Matthew J. Schellenberg(Mayo Clinic)
Cited by 309
Related Papers
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
|Nature Genetics|2010|1.1k
A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics
|Nature Protocols|2009|783
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
|Journal of Biological Chemistry|2001|737